Detalhe da pesquisa
1.
A predictive and prognostic model for surgical outcome and prognosis in ovarian cancer computed by clinico-pathological and serological parameters (CA125, HE4, mesothelin).
Clin Chem Lab Med
; 62(3): 530-539, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37816681
2.
Exploring evolutionary trajectories in ovarian cancer patients by longitudinal analysis of ctDNA.
Clin Chem Lab Med
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38577791
3.
The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy.
Breast Cancer Res
; 25(1): 32, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36978142
4.
Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1).
Int J Gynecol Cancer
; 33(2): 223-230, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36631151
5.
Evaluation of circulating Dickkopf-1 as a prognostic biomarker in ovarian cancer patients.
Clin Chem Lab Med
; 60(1): 109-117, 2022 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34687595
6.
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials.
Lancet Oncol
; 22(8): 1151-1161, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34252375
7.
The effect of fertility-sparing surgery on sexuality and global quality of life in women with malignant ovarian germ cell and sex cord stromal tumors: an analysis of the CORSETT database of the AGO study group.
Arch Gynecol Obstet
; 304(6): 1541-1549, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34287678
8.
Serum calretinin as an independent predictor for platinum resistance and prognosis in ovarian cancer.
Int J Cancer
; 146(9): 2608-2618, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31509615
9.
Adjuvant tamoxifen but not aromatase inhibitor therapy decreases serum levels of the Wnt inhibitor dickkopf-1 while not affecting sclerostin in breast cancer patients.
Breast Cancer Res Treat
; 164(3): 737-743, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28526959
10.
Trastuzumab and survival of patients with metastatic breast cancer.
Arch Gynecol Obstet
; 296(2): 303-312, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28616827
11.
Impact of breast cancer subtypes and patterns of metastasis on outcome.
Breast Cancer Res Treat
; 150(3): 621-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25783184
12.
Treatment in Certified Breast Cancer Centers Improves Chances of Survival of Patients with Breast Cancer: Evidence Based on Health Care Data from the WiZen Study.
Geburtshilfe Frauenheilkd
; 84(2): 153-163, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38344046
13.
Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry.
Geburtshilfe Frauenheilkd
; 84(5): 459-469, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38817595
14.
Real-world treatment of German patients with recurrent and advanced endometrial cancer with a post-platinum treatment: a retrospective claims data analysis.
J Cancer Res Clin Oncol
; 149(5): 1929-1939, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35840862
15.
Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian Cancer.
Cancers (Basel)
; 15(15)2023 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37568590
16.
Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacy.
Front Pharmacol
; 14: 970457, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36817127
17.
Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy.
NPJ Breast Cancer
; 9(1): 23, 2023 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37029138
18.
RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial.
Clin Cancer Res
; 29(22): 4606-4612, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725572
19.
Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors-Results of Expression VI-Carolin Meets HANNA-Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG Survey.
Cancers (Basel)
; 15(22)2023 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38001688
20.
FNTB Promoter Polymorphisms Are Independent Predictors of Survival in Patients with Triple Negative Breast Cancer.
Cancers (Basel)
; 14(3)2022 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158735